Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cerevel Therapeutics | CERE | Jun 25, 2024 | 39.56 | -4.49 |
Chromadex | CDXC | Jun 25, 2024 | 2.44 | -4.31 |
Dyne Therapeutics | DYN | Jun 25, 2024 | 33.91 | -4.83 |
Exicure | XCUR | Jun 25, 2024 | 0.32 | -4.08 |
Fusion Pharmaceuticals | FUSN | Jun 25, 2024 | 21.55 | 0.00 |
Galapagos ADR | GLPG | Jun 25, 2024 | 25.63 | -2.10 |
Generation Bio | GBIO | Jun 25, 2024 | 2.83 | +1.43 |
Greenwich LifeSciences | GLSI | Jun 25, 2024 | 15.38 | -0.77 |
Inozyme Pharma | INZY | Jun 25, 2024 | 4.37 | -2.46 |
Inventiva ADR | IVA | Jun 25, 2024 | 3.00 | +7.73 |
iTeos Therapeutics | ITOS | Jun 25, 2024 | 14.62 | -1.81 |
Keros Therapeutics | KROS | Jun 25, 2024 | 45.65 | -1.79 |
Kintara Therapeutics | KTRA | Jun 25, 2024 | 0.30 | +13.76 |
Kronos Bio | KRON | Jun 25, 2024 | 0.95 | -6.43 |
Kymera Therapeutics | KYMR | Jun 25, 2024 | 31.15 | -0.95 |
Legend Biotech ADR | LEGN | Jun 25, 2024 | 43.52 | +1.00 |
Lyra Therapeutics | LYRA | Jun 25, 2024 | 0.26 | -1.79 |
Nautilus Biotechnology | NAUT | Jun 25, 2024 | 2.25 | +0.67 |
Nurix Therapeutics | NRIX | Jun 25, 2024 | 20.80 | -1.09 |
Nuvation Bio A | NUVB | Jun 25, 2024 | 3.04 | +1.33 |
Oric Pharmaceuticals | ORIC | Jun 25, 2024 | 6.74 | -5.73 |
PMV Pharmaceuticals | PMVP | Jun 25, 2024 | 1.68 | -0.59 |
Poseida Therapeutics | PSTX | Jun 25, 2024 | 2.58 | -6.18 |
Prelude Therapeutics | PRLD | Jun 25, 2024 | 3.79 | -3.56 |
Relay Therapeutics | RLAY | Jun 25, 2024 | 6.74 | -2.32 |
Repare Therapeutics | RPTX | Jun 25, 2024 | 3.41 | -3.67 |
Shattuck Labs | STTK | Jun 25, 2024 | 3.56 | -10.11 |
Silence Therapeutics ADR | SLN | Jun 25, 2024 | 19.95 | -2.01 |
Spruce Biosciences | SPRB | Jun 25, 2024 | 0.56 | +3.68 |
Tarsus Pharmaceuticals | TARS | Jun 25, 2024 | 25.81 | -2.36 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.